|
Guest
|
Most recent articles on angiogenesis in bladder cancer:
Targeting angiogenesis in bladder cancer.
Elfiky AA, Rosenberg JE.
Curr Oncol Rep. 2009 May;11(3):244-9.
Value of dynamic contrast-enhanced MRI and correlation with tumor
angiogenesis in bladder cancer.
Tuncbilek N, Kaplan M, Altaner S, Atakan IH, Süt N, Inci O, Demir MK.
drtuncbilek at (no spam) hotmail.com
AJR Am J Roentgenol. 2009 Apr;192(4):949-55.
A novel human AlkB homologue, ALKBH8, contributes to human bladder
cancer progression.
Shimada K, Nakamura M, Anai S, De Velasco M, Tanaka M, Tsujikawa K,
Ouji Y, Konishi N.
Cancer Res. 2009 Apr 1;69(7):3157-64.
Overexpression of cyclooxygenase-2 in urothelial carcinoma in
conjunction with tumor-associated-macrophage infiltration, hypoxia-
inducible factor-1alpha expression, and tumor angiogenesis.
Chen WT, Hung WC, Kang WY, Huang YC, Su YC, Yang CH, Chai CY.
APMIS. 2009 Mar;117(3):176-84.
A panel of angiogenic factors for early bladder cancer detection:
enzyme immunoassay and Western blot.
Eissa S, Swellam M, Labib RA, El-Zayat T, El Ahmady O.
J Urol. 2009 Mar;181(3):1353-60.
Angiotensin II type 1 receptor antagonist enhances cis-
dichlorodiammineplatinum-induced cytotoxicity in mouse xenograft model
of bladder cancer.
Kosugi M, Miyajima A, Kikuchi E, Kosaka T, Horiguchi Y, Murai M, Oya
M.
kosugimichio at (no spam) hotmail.com
Urology. 2009 Mar;73(3):655-60.
InTextoResearch, Baelen, Ličge, Wallonie (Wallonia), Belgique
(Belgium) & Agence Wallonne d’Information Scientifique (AWIS) (Marc
Lacroix, scimedweb at (no spam) mail.com) |
|
|
